Navan Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human stem and primary cells. The patented Nanostraw technology provides direct intracellular access into hard-to-transfect stem and primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost, and technical difficulties) are eliminated, resulting in fewer, faster operational steps.
For more information on Navan, please visit www.navanbio.com.
